FDA orders manufacturers to stop selling gynecologic mesh
Editor's Note The Food and Drug Administration (FDA) on April 16 announced that it had ordered manufacturers of surgical mesh products indicated for transvaginal repair of pelvic organ prolapse to stop selling and distributing their products in the US, immediately. The FDA has determined that manufacturers, Boston Scientific and Coloplast,…
FDA: Class I recall of Brainlab Spine & Trauma 3D Navigation Software
Editor's Note The Food & Drug Administration (FDA) on April 15 identified the recall of Brainlab's Spine & Trauma 3D Navigation Software as Class I, the most serious. The Software is being recalled because of the potential for incorrect information to display during surgery, which may prevent the surgeon from…
FDA issues Safety Communication on cybersecurity vulnerabilities in Medtronic cardiac devices
Editor's Note The Food & Drug Administration on March 21 issued a Safety Communication on cybersecurity vulnerabilities identified in wireless telemetry technology used for communication between Medtronic’s implantable cardiac devices, clinic programmers, and home monitors. Medtronic (Dublin, Ireland) is working on updates to address the vulnerabilities and recommends that healthcare…
FDA issues warning letters to two breast implant manufacturers
Editor's Note The Food & Drug Administration (FDA) on March 19 issued warning letters to two breast implant manufacturers (Mentor Worldwide LLC of Irvine, California, and Sientra, Inc of Santa Barbara, California) for failing to comply with post-approval study requirements. All manufacturers of approved silicone gel-filled implants are required to…
FDA: Class I recall of Cook Medical’s Transseptal Needle
Editor's Note The Food and Drug Administration on March 18 identified the recall by Cook Medical Inc (Bloomington, Indiana) of one lot of its Transseptal Needles as Class I, the most serious. The recall was initiated because of a manufacturing error that resulted in some needle tips missing the back…
FDA: Hospira recalls 8.4% Sodium Bicarbonate Injection
Editor's Note The Food and Drug Administration (FDA) on March 15 announced the recall by Hospira, Inc (a Pfizer company) of three lots of its 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL). The recall was initiated because of the presence of particulate matter, confirmed as glass. The…
FDA: Guardian Pharmacy ordered to stop producing sterile compounded drugs
Editor's Note The Food & Drug Administration on March 12 announced that a federal judge entered a consent decree against Guardian Pharmacy Services (Dallas, Texas) to stop the company from producing compounded drug products intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic (FD&C)…
FDA: Class I recall of RVO 2.0 Raindrop near vision inlay
Editor's Note The Food & Drug Administration (FDA) on March 5 identified the recall by RVO 2.0, Inc (Aliso Viejo, California) of its Raindrop near vision inlay as Class I, the most serious. All lots of the inlay are being recalled because data from the post-approval study showed an increased…
FDA: Class I recall of Physio-Control LIFEPAK 15 Monitor/Defibrillator
Editor's Note The Food & Drug Administration (FDA) on February 27 identified the recall by Physio-Control, Inc (Redmond, Washington) of its LIFEPAK 15 Monitor/Defibrillator as Class I, the most serious. The recall was initiated because the device may “lockup” (freeze) after a shock is delivered. Once it freezes, it cannot…
FDA: Class I recall of ICU Medical’s ChemoLock Vial Spike
Editor's Note The Food & Drug Administration (FDA) on February 22 identified the recall by ICU Medical (San Clemente, California) of its ChemoLock Vial Spike (20 mm) as Class I, the most serious. The recall was initiated because of the potential for plastic particles to break off the protective cap.…
Free Daily News
- Study: High-paying medical specialty disparity persists as more women pursue surgical professions
- Study quantifies link between preoperative depression, postoperative delirium
- Cardiovascular disease trends raise alarms on primary care
- Study: Kidney transplants safe between donors, patients with HIV
- Study: Women more likely to die from postoperative complications after high-risk surgery
- Study: Same-day aquablation surgery safe for ASCs
- Outpatient, ASC clinicians share perspectives on upcoming NOPAIN Act implementation
- Study dispels orthopedic surgeon turnover myth
- Feds take action on Hurricane-wracked medical supply chain with wartime powers, drug compounding guidance
- Study: Wearable devices improve postoperative physical activity in lung cancer patients